IBM and Israeli generic drug giant Teva will partner to develop treatments for chronic conditions using the Watson Health Cloud.
Their stated goal is “to put the best information and insights in the hands of physicians, care teams and patients, to empower treatment optimization for individuals and populations across the spectrum of acute and chronic conditions.” Asthma, pain, migraine and neurodegenerative diseases are early targets.
The big data / pharma partnership could reduce drug misuse or increase adherence. A joint research team will develop platforms to model diseases and potential therapeutic treatments.